BREFX
Price
$40.62
Change
-$0.10 (-0.25%)
Updated
Aug 15 closing price
Net Assets
2.24B
VGSLX
Price
$127.04
Change
+$0.67 (+0.53%)
Updated
Aug 15 closing price
Net Assets
63.72B
Interact to see
Advertisement

BREFX vs VGSLX

Header iconBREFX vs VGSLX Comparison
Open Charts BREFX vs VGSLXBanner chart's image
Baron Real Estate Retail
Price$40.62
Change-$0.10 (-0.25%)
VolumeN/A
Net Assets2.24B
Vanguard Real Estate Index Admiral
Price$127.04
Change+$0.67 (+0.53%)
VolumeN/A
Net Assets63.72B
BREFX vs VGSLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BREFX vs. VGSLX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BREFX is a Buy and VGSLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSLX has more cash in the bank: 63.7B vs. BREFX (2.24B). VGSLX pays higher dividends than BREFX: VGSLX (3.89) vs BREFX (0.16). BREFX was incepted earlier than VGSLX: BREFX (16 years) vs VGSLX (24 years). BREFX (1.31) is less costly to investors than VGSLX (0.13). BREFX is a more actively managed with annual turnover of: 77.00 vs. VGSLX (7.00). BREFX has a lower initial minimum investment than VGSLX: BREFX (2000) vs VGSLX (3000). BREFX annual gain was more profitable for investors over the last year : 11.83 vs. VGSLX (1.35). VGSLX return over 5 years is better than : 32.93 vs. BREFX (30.94).
BREFXVGSLXBREFX / VGSLX
Total Expense Ratio1.310.131,008%
Annual Report Gross Expense Ratio1.310.131,008%
Fund Existence16 years24 years-
Gain YTD4.4482.048217%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.24B63.7B4%
Annual Yield % from dividends0.163.894%
Returns for 1 year11.831.35877%
Returns for 3 years24.88-0.62-4,021%
Returns for 5 years30.9432.9394%
Returns for 10 years54.6355.8298%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
CRL156.680.88
+0.56%
Charles River Laboratories International
CUB10.500.01
+0.10%
Lionheart Holdings
OACCU10.57N/A
N/A
Oaktree Acquisition Corp III Life Sciences
TRS36.77-0.20
-0.54%
TriMas Corp